Jenny Ahlstrom, Multiple Myeloma Hero and founder of Myeloma Crowd, discusses how patients can help expedite the process to finding a cure. Everyone has something to give, Ahlstrom emphasizes, be it joining a clinical trial or simply sharing information on the disease.
Jenny Ahlstrom, Multiple Myeloma Hero and founder of Myeloma Crowd, discusses how patients can help expedite the process to finding a cure. Everyone has something to give, Ahlstrom emphasizes, be it joining a clinical trial or simply sharing information on the disease.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More